Literature DB >> 8830223

[Mycobacterium ulcerans cutaneous infections: Buruli ulcers].

R Josse1, A Guedenon, H Darie, S Anagonou, F Portaels, W M Meyers.   

Abstract

Mycobacterium ulcerans skin infection or Buruli ulcers are common in children in many rural tropical areas. The usual clinical appearance is a deep, rapidly developing chronic ulcer associated with necrosis of subcutaneous fat. Patients are usually seen at an advanced stage. Bacteriologic identification is not always possible because the pathogen, Mycobacterium ulcerans, is an atypical mycobacteria that is difficult to isolate and grows slowly in culture. Medium although of little assistance in tropical regions, the histological features are highly characteristic and can allow diagnosis in areas in which the disease is rare and unsuspected. The pathogenic effects of Mycobacterium ulcerans are due to the production of a necrotizing exotoxin with an immunosuppressive action. Treatment using antituberculosis and antileprosy drugs has been disappointing. Surgery is usually required and causes extensive sequels in many cases, the best technique being an excision/graft procedure. Many epidemiologic characteristics of Buruli ulcers which are andemic in regions with and aquatic ecosystem are still unclear including the mode of infection, transmission and reservoir. Recent outbreaks, particularly in west Africa, may be related to changes in the natural environment.

Entities:  

Mesh:

Year:  1995        PMID: 8830223

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  15 in total

Review 1.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

2.  Comparison of two PCRs for detection of Mycobacterium ulcerans.

Authors:  A Guimaraes-Peres; F Portaels; P de Rijk; K Fissette; S R Pattyn; J van Vooren; P Fonteyne
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

3.  Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system.

Authors:  J C Palomino; F Portaels
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

Review 4.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

5.  Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization.

Authors:  F Portaels; J Agular; K Fissette; P A Fonteyne; H De Beenhouwer; P de Rijk; A Guédénon; R Lemans; C Steunou; C Zinsou; J M Dumonceau; W M Meyers
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

6.  Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.

Authors:  A Bentoucha; J Robert; H Dega; N Lounis; V Jarlier; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

7.  In vitro susceptibility of Mycobacterium ulcerans to clarithromycin.

Authors:  F Portaels; H Traore; K De Ridder; W M Meyers
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Excision of pre-ulcerative forms of Buruli ulcer disease: a curative treatment?

Authors:  K-H Herbinger; D Brieske; J Nitschke; V Siegmund; W Thompson; E Klutse; N Y Awua-Boateng; E Bruhl; L Kunaa; M Schunk; O Adjei; T Löscher; G Bretzel
Journal:  Infection       Date:  2008-12-03       Impact factor: 3.553

9.  Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001.

Authors:  Martine Debacker; Julia Aguiar; Christian Steunou; Claude Zinsou; Wayne M Meyers; Augustin Guédénon; Janet T Scott; Michèle Dramaix; Françoise Portaels
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

10.  Risk factors for Buruli ulcer, Benin.

Authors:  Martine Debacker; Frangoise Portaels; Julia Aguiar; Christian Steunou; Claude Zinsou; Wayne Meyers; Michèle Dramaix
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.